Bridge GLP compliant drug development in China

Press Releases

2010 Releases
January
11

Pharmaron Expands Portfolio of Services with Acquisition of Bridge Laboratories China

2008 Releases
September
02

Bridge Laboratories announced today that data from its China lab has been accepted by the FDA.

July
29

Bridge Laboratories Reaches Agreement to Build 2nd Facility in Beijing

2007 Releases
August
6

Bridge Laboratories' China Facility Receives Full AAALAC Accreditation: First Preclinical CRO with US and China Multispecies Capabilities

February
1

Bridge Announces the CRO Industry’s First China-US Visiting Scholar Program for Its Employees

2006 Releases
October
6

Wan Yang Feng, Ph.D. has been appointed Director of Bioanalytic and Metabolism of Bridge Pharmaceutical's Preclinical Laboratory in Beijing

September
6

Bridge Successfully Validates Beijing Preclinical Laboratory

June
9

Bridge Laboratories Purchases Provantis Solution for New GLP Laboratory in China

2005 Releases
November
22

San Francisco Business Times: Bridging the biopharmaceutical gap with a new Chinese Lab

November
22

Bridge Laboratories Dedicates Its Preclinical Drug Development Laboratory in Beijing